Year of Publication Titlesort descending Faculty Association
2017 Sex differences in Alzheimer risk: Brain imaging of endocrine vs chronologic aging. Roberta Diaz Brinton, Ph.D
2016 Sex differences in metabolic aging of the brain: insights into female susceptibility to Alzheimer's disease. Roberta Diaz Brinton, Ph.D
2021 Sex hormones regulate NHE1 functional expression and brain endothelial proteome to control paracellular integrity of the blood endothelial barrier. Erika Liktor-Busa, PhD, PharmD, Tally Largent-Milnes, PhD, Todd Vanderah, PhD
2011 Shift in brain metabolism in late onset Alzheimer's disease: implications for biomarkers and therapeutic interventions. Roberta Diaz Brinton, Ph.D
2017 Sonogashira diversification of unprotected halotryptophans, halotryptophan containing tripeptides; and generation of a new to nature bromo-natural product and its diversification in water Christopher Cartmell
2019 Sphingosine-1-phosphate receptor 1 activation in astrocytes contributes to neuropathic pain. Tally Largent-Milnes, PhD, Todd Vanderah, PhD
2015 Spinal dopaminergic projections control the transition to pathological pain plasticity via a D1/D5-mediated mechanism. Patrick W Mantyh
2010 Spinal or systemic TY005, a peptidic opioid agonist/neurokinin 1 antagonist, attenuates pain with reduced tolerance. Tally Largent-Milnes, PhD, Frank Porreca, PhD, Todd Vanderah, PhD
2014 Src-mediated post-translational regulation of endoglin stability and function is critical for angiogenesis. Nam Lee, Ph.D.
2021 Stroke Treatment With PAR-1 Agents to Decrease Hemorrhagic Transformation. Thomas P Davis, PhD
2020 Structure, Function, and Regulation of the Blood-Brain Barrier Tight Junction in Central Nervous System Disorders. Thomas P Davis, PhD, Jeffrey J. Lochhead, PhD, Patrick T Ronaldson, PhD, FAAPS
2014 Structure-activity relationships of non-opioid [des-Arg(7)]-dynorphin A analogues for bradykinin receptors. Frank Porreca, PhD
2012 Structure-activity relationships of trimethoxybenzyl piperazine N-type calcium channel inhibitors. Frank Porreca, PhD, Todd Vanderah, PhD
2016 Structure-Activity Relationships of [des-Arg(7)]Dynorphin A Analogues at the κ Opioid Receptor. Victor Hruby, Ph.D., Tally Largent-Milnes, PhD, Frank Porreca, PhD, John M. Streicher, PhD, Todd Vanderah, PhD
2010 Sustained morphine-mediated pain sensitization and antinociceptive tolerance are blocked by intrathecal treatment with Raf-1-selective siRNA. Tally Largent-Milnes, PhD, Todd Vanderah, PhD
2017 Synergistic attenuation of chronic pain using mu opioid and cannabinoid receptor 2 agonists. Mohab M. Ibrahim, PhD, MD, Tally Largent-Milnes, PhD, Todd Vanderah, PhD
2011 Synthesis and biological evaluation of new opioid agonist and neurokinin-1 antagonist bivalent ligands. Peg Davis, Victor Hruby, Ph.D., Josephine Lai , Ph.D., Frank Porreca, PhD, Todd Vanderah, PhD, Eva Varga, Ph.D.
2014 Synthesis and evaluation of bivalent ligands for binding to the human melanocortin-4 receptor.
2022 Synthesis of ()()-Tiruchanduramine. Christopher Cartmell
2011 Synthesis of conolidine, a potent non-opioid analgesic for tonic and persistent pain. John M. Streicher, PhD
2017 Synthetic analogues of cyanobacterial alkaloid cylindrospermopsin and their toxicological activity. Christopher Cartmell
2012 Tachykinin NK₁ receptor antagonist co-administration attenuates opioid withdrawal-mediated spinal microglia and astrocyte activation. Victor Hruby, Ph.D., Tally Largent-Milnes, PhD, Todd Vanderah, PhD, Eva Varga, Ph.D.
2022 Targeting 5-HT receptors and Kv7 channels in PFC to attenuate chronic neuropathic pain in rats using a spared nerve injury model. Tally Largent-Milnes, PhD, Arthur Charles Riegel, Todd Vanderah, PhD
2017 Targeting a Potassium Channel/Syntaxin Interaction Ameliorates Cell Death in Ischemic Stroke.
2011 Targeting mitochondrial bioenergetics for Alzheimer's prevention and treatment. Roberta Diaz Brinton, Ph.D